Events are invaluable to moving global health forward. They are opportunities to exchange insight, test out new ideas, and make connections.
All Dahdaleh Institute events are free and open to the public, unless otherwise noted.
Artificial intelligence (A.I.) brings fundamental change in our lives, affecting everything from business to government; working life to personal time. As increasingly sophisticated AI systems are created and used more widely, the effects on our health are unclear.
Effects on labour markets and employment are popular areas of public concern and debate, but the potential societal effects of A.I. extend more broadly. Questions have been raised about fundamental and complex topics such as algorithmic bias, transparency, governance, and inclusion.
This panel will examine diverse topics including ethics, policymaking and the health of our cities.
Our speakers will provide an overview of key A.I. concepts, their cross-cutting policy implications, and consider what health equity considerations we must undertake when thinking about the use of AI in the GTA.
Jennifer Gibson, Director, University of Toronto’s Joint Centre for Bioethics
Vass Bednar, Head of Public Policy, Delphia
Moderated by Kwame McKenzie, CEO, Wellesley Institute
Doors will open at 6 p.m. Event will begin promptly at 6:30 p.m. Light refreshments will be served.
If cost is a barrier, you require information in an alternative format, or have concerns related to the accessibility of this event, please contact firstname.lastname@example.org.
NOTE: This is not a DIGHR event
The World Health Organization and guideline development: What have we learned a decade after major reforms?
Dr. Unni Gopinathan is a postdoctoral fellow in the department of population medicine at the Harvard Pilgrim Health Care Institute, associate professor at the University of Oslo, and a GSL post doctoral fellow.
Designers are increasingly involved in the world of social good. Traditionally installed in commercial sectors, they are now collaborating with scientists, researchers and others non-designers with their own knowledge-base and processes. These interdisciplinary encounters are often new, exciting and challenging.
Drawing on her experiences of this phenomenon, and on the research behind her upcoming book Information Design for the Common Good, Courtney Marchese will lead a Lunch & Learn on interdisciplinary design collaboration in global health.
Courtney Marchese is a professional designer with over a decade of experience specializing in data visualizations, information graphics, UX design, and usability studies. She is also an Associate Professor of Graphic + Interactive Design, teaching a wide range of design theory, research, and technical skills at the undergraduate and graduate level.
To address the rising cost of medicines, patients and policymakers are increasingly turning to personal importation through Internet Pharmacies. Despite their potential to improve access to affordable medicines, most countries do not sufficiently regulate Internet Pharmacies, exacerbating public health risks.
The aim of this presentation will be twofold. Using stakeholder and supply chain mapping, the first task will be to determine if and how safety and quality of medicines sold over the Internet can be protected. The broader objective will be to apply a public health framework to evaluate emerging strategies of regulating Internet Pharmacies. In addition to mainstream proposals of expanding the jurisdictional scope of existing regulatory authorities, we consider disruptive internet governance strategies that delegate public health functions to technology intermediaries.
Aria Ilyad Ahmad is the Global Health Foresighting Research Fellow at the Dahdaleh Institute for Global Health Research. Since 2014, he has also served as a consultant to the World Health Organization's Department of Essential Medicines and Health Products. Aria is a past Duke University Global Health Fellow and past faculty member of the Global Health Education Initiative at the University of Toronto. He has testified before the Canadian Senate on Canada’s Access to Medicines Regime, served on the board of directors of Universities Allied for Essential Medicines, and was the inaugural Médecins Sans Frontières Access to Medicines Fellow in India. Aria received his HBSc and MSc in international pharmaceutical policy from the University of Toronto, and is completing his PhD in global health governance at the Balsillie School of International Affairs in Waterloo, Canada.
South Africa has the third highest burden of tuberculosis (TB) and the highest burden of TB-HIV co-infection globally. Efforts to curb TB have focussed on strengthening the public sector. Yet, a third of South Africans with active TB symptoms first seek care in the private sector where the quality of care remains poorly understood. In this talk, Angela Salomon will present an ongoing study (2017-2020) utilising the standardised patient (SP) methodology to determine how TB and TB-HIV are managed among private general practitioners (GPs) in an urban area of KwaZulu-Natal province. Eight healthy SPs underwent extensive training in typical TB case presentations and completed 220 unannounced visits with 96 consenting GPs. The results of these clinical interactions as a means to assess quality of care for TB and TB-HIV are presented in this talk.
Angie Salomon, MPH, is a medical student at Queen's University in Kingston, Ontario. She works with Assistant Professor Dr. Amrita Daftary (Global Health, York University) and is a research assistant with the McGill International Tuberculosis Centre. There, Angie conducts data management and analysis on a study of the quality of tuberculosis care in South Africa using standardized patients. She also performs a systematic review on interventions to improve linkage gaps along TB-HIV care cascades in low and middle-income countries.
Angie completed her MPH in Epidemiology at the Dalla Lana School of Public Health, University of Toronto, where she explored quantitative and mixed-methods research in infectious diseases and maternal health, both at home and abroad. During this time, she worked with the Population Council in Abuja, Nigeria, assessing quality of antenatal care as it pertains to pre-eclampsia and eclampsia. She had previously worked with Grand Challenges Canada as a program assistant for Every Woman Every Child Innovation Marketplace.
Passionate about health equity, Angie works to measure and improve the quality of healthcare delivery locally and globally.
Policymakers across all political stripes and jurisdictions are being confronted with the realities of a health system under immense pressure - the sustainability of which is being challenged by a growing and aging population.
Charting that path to sustainability has been the core concern of the Canada 2020 Health Innovation Summit. Now in its fifth year, the Summit will look at how advancements in technology and investments in innovation help improve health outcomes and reduce costs.
This year, we will also be analyzing the ways in which these advancements interact with the implementation of a Pharmacare plan.
Bringing together key representatives from across the health system (federal and provincial policymakers, hospital executives, patient advocates, industry leaders and researchers), the Canada 2020 Health Innovation Summit will be structured around keynotes, presentations, panel discussions and networking.
Registration is now open. Early bird prices available until January 31st, 2020
Note: exact timing subject to change
9:00 Registration & Welcome from Canada 2020
9:15 Welcoming Presentation
Dr. Sandy Buchman, President, Canadian Medical Association
9:30 Presentation: Health Care Costs, Demographic Pressures & Emerging Challenges
Mostafa Askari, Chief Economist, IFSD, uOttawa
10:00 Panel Discussion: Growing the Health Innovation Ecosystem
Matthew Collingridge, General Manager, Digital, GE Healthcare
Kathryn Hughes, TELUS Health
Janet Daglish, National Director, Bayshore
Moderated by Bill Charnetski, EVP Point-and-Click Care
11:00 Presentation: Stepping into the Future of Treatment & Care in Canada
Elizabeth Toller, Executive Director, Regulatory Innovation, Health Canada
David Lee, Chief Regulatory Officer, Health Canada
12:00 Networking Lunch & Conversation
The Hon. Mary Ng, Minister of Small Business, Export Promotion and International Trade
13:15 In Conversation: Adopting Innovation on the Front Lines
Alex Munter, President & CEO, CHEO
Jodi Butts, Independent Board Member
14:00 Special Presentation: Global Context, Global Risks
Dr. James Orbinski, Dahdeleh Centre for Global Health Research, York University
15:00 The 3 P’s of Health Politics in 2020 - Pharmacare, Provinces & Pandemic
Tim Powers, Summa Strategies
Anne McGrath, National Director, NDP
Peter Cleary, Santis Health
16:00 Conclusion of forum